Globus Medical, Inc. (GMED) News

Globus Medical, Inc. (GMED): $56.29

1.03 (+1.86%)

POWR Rating

Component Grades








Filter GMED News Items

GMED News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GMED News Highlights

  • For GMED, its 30 day story count is now at 5.
  • Over the past 12 days, the trend for GMED's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • FRO, GAME and PATH are the most mentioned tickers in articles about GMED.

Latest GMED News From Around the Web

Below are the latest news stories about GLOBUS MEDICAL INC that investors may wish to consider to help them evaluate GMED as an investment opportunity.

4 Orthobiologic Stocks Set To Soar In 2024

Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery fro...

Yahoo | December 19, 2023

Here's Why You Should Retain Globus Medical (GMED) Stock Now

Investors are optimistic about Globus Medical (GMED) on growing demand for musculoskeletal devices and its strong solvency position.

Yahoo | December 15, 2023

3 Stocks at the Forefront of Medical Robotics

Every now and then, speculation – within carefully defined limits – may be appropriate, which brings us to the case for medical robotics stocks to buy.

Josh Enomoto on InvestorPlace | December 10, 2023

Globus Medical (GMED) Down 3.1% Since Last Earnings Report: Can It Rebound?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 7, 2023

Globus Medical (GMED) Gains From NuVasive Deal, Macro Woes Stay

Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.

Yahoo | December 7, 2023

Globus Medical, Inc. (NYSE:GMED) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined...

Yahoo | December 1, 2023

Globus Medical, Inc. (NYSE:GMED) Q3 2023 Earnings Call Transcript

Globus Medical, Inc. (NYSE:GMED) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Thank you for standing by, and welcome to the Globus Medical Third Quarter 2023 Earnings Call. [Operator Instructions]. I will now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations. Mr. Kearns, please go ahead. […]

Yahoo | November 8, 2023

Globus Medical (GMED) Q3 Earnings Top Estimates, Margins Down

Globus Medical's (GMED) legacy business continues to drive share growth across its U.S. spine and trauma portfolios in the third quarter.

Yahoo | November 8, 2023

Globus Medical (GMED) Q3 2023 Earnings Call Transcript

Thank you for standing by, and welcome to the Globus Medical third-quarter 2023 earnings call. Joining today's call for Globus Medical will be Dan Scavilla, president and CEO; and Keith Pfeil, chief financial officer. This review is being made available via webcast accessible through Investor Relations section of the Globus Medical website at

Yahoo | November 8, 2023

Globus Medical (GMED) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Globus Medical (GMED) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Yahoo | November 8, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!